Icares Medicus Inc
ICARES Medicus, Inc., together with its subsidiaries, engages in the research, development, manufacturing, and sale of ophthalmic medical devices in Taiwan, the United States, England, Japan, Spain, China, and internationally. The company is also involved in the manufacturing, sales, and service of intraocular lenses (IOLs) and its implantation systems for use in treating cataracts, myopia, hyper… Read more
Icares Medicus Inc (6612) - Total Liabilities
Latest total liabilities as of September 2025: NT$1.25 Billion TWD
Based on the latest financial reports, Icares Medicus Inc (6612) has total liabilities worth NT$1.25 Billion TWD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Icares Medicus Inc - Total Liabilities Trend (2017–2024)
This chart illustrates how Icares Medicus Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Icares Medicus Inc Competitors by Total Liabilities
The table below lists competitors of Icares Medicus Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
6934
TWO:6934
|
Taiwan | NT$87.87 Million |
|
Ta-Yuan Cogeneration Co Ltd
TWO:8931
|
Taiwan | NT$3.03 Billion |
|
ASICLAND
KQ:445090
|
Korea | ₩96.24 Billion |
|
Hydratec Industries NV
AS:HYDRA
|
Netherlands | €104.49 Million |
|
Plotech Co Ltd
TW:6141
|
Taiwan | NT$4.51 Billion |
|
Neontech Co. Ltd
KQ:306620
|
Korea | ₩105.48 Billion |
|
Advanced Lithium Electrochemistry Cayman Co Ltd
TWO:5227
|
Taiwan | NT$818.68 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Icares Medicus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.72 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Icares Medicus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Icares Medicus Inc (2017–2024)
The table below shows the annual total liabilities of Icares Medicus Inc from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | NT$1.25 Billion | +419.36% |
| 2023-12-31 | NT$239.80 Million | +126.98% |
| 2022-12-31 | NT$105.65 Million | -27.12% |
| 2021-12-31 | NT$144.96 Million | -0.45% |
| 2020-12-31 | NT$145.62 Million | +4.75% |
| 2019-12-31 | NT$139.02 Million | +202.46% |
| 2018-12-31 | NT$45.96 Million | -29.19% |
| 2017-12-31 | NT$64.91 Million | -- |